Are you dealing with male infertility?

We are looking for men with low sperm count to take part in a clinical trial.

See if you qualify

How It Works



Complete our form and someone will contact you to make sure you meet all eligibility requirements


Sign the informed consent and go through the screening process


Enroll in the clinical trial and get started

How You Might Benefit from Trial Participation

Increased Chance of Spontaneous Pregnancy

ADAM trial participants might benefit in the form of an improvement in their sperm quality and by achieving pregnancy of their female partners. If you choose to participate in the trial, the cost of the trial drug, trial-related procedures and tests will be paid for by the trial sponsor.

Extended Fertility Support for Completing Trial Requirements

ADAM trial participants who complete 6 months of trial treatment will be offered cryopreservation (freezing) of semen samples for future use in assisted reproductive technology (ART) and other infertility treatment (if permitted by local laws and regulations for up to 1 year). Those who complete 6 months of trial treatment without achieving pregnancy may also be offered up to $10,000 of financial reimbursement to offset the cost of qualifying infertility treatment outside the trial (initiated and submitted for reimbursement within 9 months of the end-of-treatment visit).

Who Can Participate
  • You are 18-50 years old
  • Your female partner is 18-38 years old
  • As a couple, you have a history of infertility for 6 months to 5 years
  • You have a Body Mass Index (BMI) ≤ 40 kg/m2
  • You do not have a history of drug abuse within 12 months prior to screening

This is not a complete list of study requirements. Additional participation requirements will be shared by the study staff upon completion of the form available on this site.


This clinical trial is actively seeking participants at these locations throughout the United States:

See if you qualify



Reproductive Medicine and Maternal Health

© 2024 Ferring.

Ferring and the Ferring Pharmaceuticals logo and, unless otherwise specified, all product names and service names are trademarks owned by, or licensed to, the Ferring group of companies. All other trademarks are the property of their respective owner(s).

US-RMMH-2300161 v3